
NYSEHealthcareMedical - Diagnostics & Research
Latest quote
$220.36
−$7.20 · -3.16%
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Previous close
$220.36
−$7.20 · -3.16%
Regular session · ET · Market data may be delayed.
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Day range
Current $220.36
52-week range
Current $220.36
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
69
Undervalued
Sentiment
68
Bullish
Risk
30
Moderate Risk
Momentum
48
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Day range
Current $220.36
52-week range
Current $220.36
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 24.57B USD | 23.88B USD | 23.89B USD | 26.64B USD | 29.45B USD |
| Cost of goods sold | 9.61B USD | 9.67B USD | 9.86B USD | 10.46B USD | 11.5B USD |
| Gross profit | 14.96B USD | 14.21B USD | 14.03B USD | 16.19B USD | 17.95B USD |
| Research and development | 1.6B USD | 1.58B USD | 1.5B USD | 1.53B USD | 1.74B USD |
| Selling, general, and administrative | 8.24B USD | 7.44B USD | 7.25B USD | 7.12B USD | 8.2B USD |
| Operating expenses | 10.27B USD | 9.34B USD | 8.83B USD | 8.65B USD | 10.49B USD |
| Interest income | 30M USD | 117M USD | 303M USD | 41M USD | 11M USD |
| Interest expense | 265M USD | 278M USD | 289M USD | 207M USD | 241M USD |
| Depreciation and amortization | 2.45B USD | 2.35B USD | 2.17B USD | 2.13B USD | 2.17B USD |
| Operating income | 4.69B USD | 4.86B USD | 5.2B USD | 7.54B USD | 7.47B USD |
| Net income | 3.61B USD | 3.9B USD | 4.76B USD | 7.21B USD | 6.43B USD |
Company facts updated Nov 22, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$244.63
11.01% upsideCash distributions grouped by calendar year; partial years are marked.
$1.28
2025 complete year+71.9% since 2021
2026 partial: $1.20
$0.7447
2,021
$0.8865
2,022
$0.9887
2,023
$1.08
2,024
$1.28
2,025
$1.20
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Sep 30, 2026 | $0.40Quarterly | Sep 30, 2026 | Oct 30, 2026 |
Dividend | Jun 26, 2026 | $0.40Quarterly | Jun 26, 2026 | Jul 31, 2026 |
Dividend | Mar 27, 2026 | $0.40Quarterly | Mar 27, 2026 | Apr 24, 2026 |
Dividend | Dec 26, 2025 | $0.32Quarterly | Dec 26, 2025 | Jan 30, 2026 |
Dividend | Sep 26, 2025 | $0.32Quarterly | Sep 26, 2025 | Oct 31, 2025 |
Dividend | Jun 27, 2025 | $0.32Quarterly | Jun 27, 2025 | Jul 25, 2025 |
Ex-dividend Sep 30, 2026
$0.40
Quarterly
Record Sep 30, 2026 · Payment Oct 30, 2026
Ex-dividend Jun 26, 2026
$0.40
Quarterly
Record Jun 26, 2026 · Payment Jul 31, 2026
Ex-dividend Mar 27, 2026
$0.40
Quarterly
Record Mar 27, 2026 · Payment Apr 24, 2026
Ex-dividend Dec 26, 2025
$0.32
Quarterly
Record Dec 26, 2025 · Payment Jan 30, 2026
Ex-dividend Sep 26, 2025
$0.32
Quarterly
Record Sep 26, 2025 · Payment Oct 31, 2025
Ex-dividend Jun 27, 2025
$0.32
Quarterly
Record Jun 27, 2025 · Payment Jul 25, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR S&P 500 ETF1557.T275.08B0.23%119.93T JPY0.09%¥113,700-3.19%
Vanguard S&P 500 ETFVOO3.86B0.22%1T USD0.03%$635.54-3.41%
Vanguard Morningstar Total Stock Market ETFVTI3.68B0.20%689.3B USD0.03%$340.02-3.52%
iShares Core S&P 500 ETFIVV1.86B0.23%803.41B USD0.03%$693.71-3.52%
State Street SPDR S&P 500 ETFSPY1.74B0.23%756.38B USD0.09%$689.81-3.64%
Vanguard Morningstar Value ETFVTV1.41B0.53%195.9B USD0.03%$214.22-1.62%
State Street Health Care Select Sector SPDR ETFXLV1.04B2.21%46.92B USD0.08%$177.24-0.12%
Vanguard Dividend Appreciation ETFVIG821.03M0.60%115.8B USD0.04%$235.69-1.87%
State Street SPDR S&P 500 ETF1557.T
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Total Stock Market ETFVTI
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Dividend Appreciation ETFVIGAI-generated and delayed market data for informational and educational purposes only. Not investment advice.